Mary Catherine Walton Cabrera

Title: Mary Catherine Walton Cabrera: Innovator in Cancer Treatment

Introduction

Mary Catherine Walton Cabrera is a prominent inventor based in Camarillo, CA. She has made significant contributions to the field of cancer research through her innovative work on KIF18A inhibitors. Her research focuses on compounds that can modulate the KIF18A protein, which plays a crucial role in the cell cycle and cell proliferation.

Latest Patents

Mary Catherine holds 1 patent related to her groundbreaking work. The patent details compounds of formula (I) that are capable of influencing the KIF18A protein, thereby providing potential treatments for cancer and cancer-related diseases. The invention also encompasses pharmaceutical compositions that include these compounds and methods for treating disease states associated with KIF18A activity.

Career Highlights

Mary Catherine is currently employed at Amgen Inc., a leading biotechnology company. Her role at Amgen allows her to further her research and development efforts in the field of oncology. Her work is instrumental in advancing therapeutic options for patients suffering from cancer.

Collaborations

Throughout her career, Mary Catherine has collaborated with notable colleagues, including Nuria A Tamayo and Abhisek Banerjee. These collaborations have enriched her research and contributed to the development of innovative solutions in cancer treatment.

Conclusion

Mary Catherine Walton Cabrera is a dedicated inventor whose work on KIF18A inhibitors represents a significant advancement in cancer therapy. Her contributions to the field are paving the way for new treatment options that could benefit countless patients.